Twin Focus Capital Partners’s iShares Biotechnology ETF IBB Stock Holding History

Twin Focus Capital Partners’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-3,066	Closed	-$518K	–	173
2026 Q1	$518K	Hold	3,066	–	–	0.06%	130
2025 Q4	$517K	Hold	3,066	–	–	0.06%	128
2025 Q3	$443K	Buy	+3,066	New	+$419K	0.06%	133
2025 Q2	–	Sell	-10,697	Closed	-$1.37M	–	173
2025 Q1	$1.37M	Sell	10,697 -150	-1%	-$20.3K	0.21%	70
2024 Q4	$1.43M	Sell	10,847 -1,399	-11%	-$197K	0.21%	67
2024 Q3	$1.78M	Buy	12,246 +1	+0%	+$145	0.28%	58
2024 Q2	$1.68M	Buy	12,245 +803	+7%	+$107K	0.27%	58
2024 Q1	$1.57M	Buy	11,442 +900	+9%	+$123K	0.3%	58
2023 Q4	$1.43M	Buy	10,542 +5,524	+110%	+$674K	0.29%	60
2023 Q3	$614K	Buy	5,018 +1,160	+30%	+$148K	0.14%	88
2023 Q2	$490K	Hold	3,858	–	–	0.1%	114
2023 Q1	$498K	Buy	3,858 +120	+3%	+$15.7K	0.1%	105
2022 Q4	$491K	Buy	+3,738	New	+$483K	0.1%	105
2014 Q4	–	Sell	-405	Closed	-$37K	–	115
2014 Q3	$37K	Buy	+405	New	+$35.5K	0.04%	106

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.9% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Twin Focus Capital Partners's IBB Position: Q2 2026 in Review

Twin Focus Capital Partners sold out of iShares Biotechnology ETF (IBB) in Q2 2026, closing a stake of 3,066 shares — an estimated $518K sold.

Twin Focus Capital Partners first reported a position in IBB in Q3 2014 and held it in 14 quarters. The position peaked at $1.78M in Q3 2024. 960 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

Twin Focus Capital Partners reported no remaining iShares Biotechnology ETF position as of Q2 2026 after selling out during the quarter.
Twin Focus Capital Partners sold 3,066 iShares Biotechnology ETF shares in Q2 2026, an estimated $518K.
Twin Focus Capital Partners first reported a position in iShares Biotechnology ETF in Q3 2014 and held it in 14 quarters.
Twin Focus Capital Partners's iShares Biotechnology ETF position peaked at $1.78M in Q3 2024.
960 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Twin Focus Capital Partners's 13F filing for Q2 2026, filed 28 Jul 2026.